Melexis N.V.
MLXSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $253 | $212 | $198 | $197 |
| % Growth | 19.4% | 6.7% | 0.4% | – |
| Cost of Goods Sold | $155 | $129 | $123 | $120 |
| Gross Profit | $98 | $83 | $76 | $78 |
| % Margin | 38.8% | 39% | 38.2% | 39.3% |
| R&D Expenses | $32 | $29 | $28 | $30 |
| G&A Expenses | $0 | $13 | $14 | $14 |
| SG&A Expenses | $21 | $18 | $18 | $20 |
| Sales & Mktg Exp. | $0 | $5 | $5 | $6 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $53 | $47 | $47 | $50 |
| Operating Income | $44 | $36 | $29 | $28 |
| % Margin | 17.6% | 16.8% | 14.6% | 14% |
| Other Income/Exp. Net | -$4 | $8 | -$0 | -$8 |
| Pre-Tax Income | $41 | $44 | $29 | $19 |
| Tax Expense | $9 | $6 | $4 | $1 |
| Net Income | $32 | $38 | $25 | $18 |
| % Margin | 12.8% | 17.9% | 12.4% | 9.3% |
| EPS | 0.81 | 0.94 | 0.61 | 0.45 |
| % Growth | -13.8% | 54.1% | 35.6% | – |
| EPS Diluted | 0.81 | 0.94 | 0.61 | 0.45 |
| Weighted Avg Shares Out | 40 | 40 | 40 | 40 |
| Weighted Avg Shares Out Dil | 40 | 40 | 40 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $8 | $0 | $0 |
| Interest Expense | $4 | $0 | $0 | $4 |
| Depreciation & Amortization | $16 | $14 | $12 | $12 |
| EBITDA | $60 | $63 | $41 | $39 |
| % Margin | 23.9% | 30% | 20.8% | 20% |